TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Current Ratio
- Current ratio · latest quarter: Value 0.88×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.88× | Current assets / current liabilities. $13.76B ÷ $15.65B ≈ 0.88× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 13.76B USD | Assets, Current |
| Current obligations | 15.65B USD | Liabilities, Current |
| Cash and equivalents | 3.65B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.49B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 3.22B USD | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | 4.50B USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $13.76B | $15.65B | $3.65B | (m) | $3.49B | $3.22B | (m) | $4.50B | 0.88× |
| 2026-03-31 | $13.71B | $13.53B | $3.74B | (m) | $3.39B | $3.18B | (m) | $2.60B | 1.01× |
| 2025-12-31 | $13.95B | $13.46B | $3.56B | (m) | $3.71B | $3.18B | (m) | $1.80B | 1.04× |
| 2025-09-30 | $12.74B | $11.49B | $2.20B | (m) | $3.81B | $3.32B | (m) | $1.00M | 1.11× |
| 2025-06-30 | $12.62B | $11.86B | $2.16B | (m) | $3.56B | $3.50B | (m) | $441.00M | 1.06× |
| 2025-03-31 | $11.53B | $11.16B | $1.70B | (m) | $3.38B | $3.25B | (m) | $398.00M | 1.03× |
| 2024-12-31 | $12.55B | $12.80B | $3.30B | (m) | $3.06B | $3.01B | $158.00M | $1.76B | 0.98× |
| 2024-09-30 | $12.31B | $13.80B | $3.32B | (m) | $3.46B | $3.96B | (m) | $2.56B | 0.89× |
| 2024-06-30 | $11.63B | $13.04B | $2.26B | (m) | $3.77B | $3.93B | (m) | $2.07B | 0.89× |
| 2024-03-31 | $12.30B | $13.79B | $2.99B | (m) | $3.46B | $3.95B | (m) | $3.04B | 0.89× |
| 2023-12-31 | $12.48B | $12.25B | $3.23B | (m) | $3.41B | $4.02B | $108.00M | $1.65B | 1.02× |
| 2023-09-30 | $11.43B | $11.39B | $2.25B | (m) | $3.38B | $4.05B | (m) | $956.00M | 1.00× |
| 2023-06-30 | $12.09B | $11.84B | $2.67B | (m) | $3.54B | $4.11B | (m) | $1.96B | 1.02× |
| 2023-03-31 | $11.50B | $10.41B | $2.14B | (m) | $3.44B | $4.12B | (m) | $1.00B | 1.10× |
| 2022-12-31 | $12.05B | $11.47B | $2.80B | (m) | $3.70B | $3.83B | (m) | $2.09B | 1.05× |
| 2022-09-30 | $11.45B | $11.53B | $2.23B | (m) | $3.73B | $3.86B | (m) | $2.75B | 0.99× |
| 2022-06-30 | $12.16B | $11.00B | $2.06B | (m) | $4.47B | $4.05B | (m) | $1.70B | 1.11× |
| 2022-03-31 | $12.45B | $11.61B | $2.17B | (m) | $4.25B | $4.01B | (m) | $2.05B | 1.07× |
| 2021-12-31 | $12.57B | $11.03B | $2.17B | (m) | $4.53B | $3.82B | (m) | $1.40B | 1.14× |
| 2021-09-30 | $12.15B | $11.82B | $2.04B | (m) | $4.05B | $4.17B | (m) | $2.39B | 1.03× |
| 2021-06-30 | $12.82B | $12.69B | $2.44B | (m) | $4.49B | $4.36B | (m) | $3.51B | 1.01× |
| 2021-03-31 | $12.40B | $12.09B | $1.74B | (m) | $4.57B | $4.41B | (m) | $2.67B | 1.03× |
| 2020-12-31 | $13.01B | $13.16B | $2.18B | (m) | $4.58B | $4.40B | (m) | $2.67B | 0.99× |
| 2020-09-30 | $12.16B | $12.10B | $1.83B | (m) | $4.38B | $4.52B | (m) | $1.47B | 1.00× |
| 2020-06-30 | $12.78B | $11.75B | $2.40B | (m) | $4.54B | $4.36B | (m) | $1.14B | 1.09× |
| 2020-03-31 | $12.88B | $12.32B | $1.80B | (m) | $5.19B | $4.29B | (m) | $1.12B | 1.05× |
| 2019-12-31 | $13.46B | $13.67B | $1.98B | (m) | $5.68B | $4.42B | (m) | $1.83B | 0.98× |
| 2019-09-30 | $12.54B | $14.11B | $1.24B | (m) | $5.25B | $4.64B | (m) | $2.52B | 0.89× |
| 2019-06-30 | $13.80B | $14.45B | $2.17B | (m) | $5.26B | $4.85B | (m) | $2.26B | 0.96× |
| 2019-03-31 | $13.43B | $14.03B | $1.97B | (m) | $5.11B | $4.78B | (m) | $2.27B | 0.96× |
| 2018-12-31 | $13.79B | $14.32B | $1.78B | (m) | $5.82B | $4.73B | (m) | $1.70B | 0.96× |
| 2018-09-30 | $13.88B | $14.83B | $1.88B | (m) | $5.67B | $4.87B | (m) | $2.16B | 0.94× |
| 2018-06-30 | $14.71B | $14.21B | $1.86B | (m) | $6.06B | $4.97B | (m) | $757.00M | 1.03× |
| 2018-03-31 | $14.69B | $14.76B | $1.42B | (m) | $6.29B | $5.11B | (m) | $786.00M | 1.00× |
| 2017-12-31 | $15.38B | $17.92B | $963.00M | (m) | $7.13B | $4.92B | (m) | $2.88B | 0.86× |
| 2017-09-30 | $16.23B | $16.94B | $680.00M | (m) | $7.42B | $5.06B | (m) | $1.90B | 0.96× |
| 2017-06-30 | $14.60B | $15.46B | $599.00M | (m) | $7.32B | $5.13B | (m) | $265.00M | 0.94× |
| 2017-03-31 | $14.84B | $15.90B | $900.00M | (m) | $7.26B | $5.00B | (m) | $835.00M | 0.93× |
| 2016-12-31 | $17.23B | $18.49B | $988.00M | (m) | $7.52B | $4.95B | (m) | $810.00M | 0.93× |
| 2016-09-30 | $17.39B | $19.29B | $1.56B | (m) | $8.07B | $5.35B | (m) | (m) | 0.90× |
| 2016-06-30 | $18.34B | $14.41B | $6.98B | (m) | $5.37B | $3.92B | (m) | (m) | 1.27× |
| 2016-03-31 | $16.99B | $12.90B | $5.96B | (m) | $5.19B | $3.96B | (m) | $950.00M | 1.32× |
| 2015-12-31 | $18.40B | $13.01B | $6.95B | (m) | $5.35B | $3.97B | (m) | $989.00M | 1.41× |
| 2015-09-30 | $12.50B | $12.98B | $928.00M | (m) | $5.28B | $4.09B | (m) | (m) | 0.96× |
| 2015-06-30 | $13.30B | $14.47B | $1.07B | (m) | $5.57B | $4.23B | (m) | (m) | 0.92× |
| 2015-03-31 | $15.71B | $12.47B | $3.40B | (m) | $5.51B | $4.17B | (m) | (m) | 1.26× |
| 2014-12-31 | $14.40B | $12.29B | $2.23B | (m) | $5.41B | $4.37B | (m) | $1.19B | 1.17× |
| 2014-09-30 | $13.92B | $11.67B | $1.47B | (m) | $5.41B | $4.59B | (m) | (m) | 1.19× |
| 2014-06-30 | $13.55B | $11.85B | $949.00M | (m) | $5.39B | $4.94B | (m) | (m) | 1.14× |
| 2014-03-31 | $13.45B | $11.40B | $901.00M | (m) | $5.28B | $4.98B | (m) | (m) | 1.18× |
| 2013-12-31 | $13.72B | $11.96B | $1.04B | (m) | $5.34B | $5.05B | (m) | $816.00M | 1.15× |
| 2013-09-30 | $13.91B | $12.16B | $1.15B | (m) | $5.19B | $5.24B | (m) | (m) | 1.14× |
| 2013-06-30 | $14.09B | $12.84B | $1.25B | (m) | $5.30B | $5.33B | (m) | (m) | 1.10× |
| 2013-03-31 | $14.42B | $12.36B | $1.39B | (m) | $5.42B | $5.38B | (m) | (m) | 1.17× |
| 2012-12-31 | $16.36B | $12.89B | $2.88B | (m) | $5.57B | $5.50B | (m) | $2.43B | 1.27× |
| 2012-09-30 | $14.98B | $10.63B | $1.43B | (m) | $5.78B | $5.46B | (m) | (m) | 1.41× |
| 2012-06-30 | $14.22B | $10.01B | $1.19B | (m) | $5.43B | $5.29B | (m) | (m) | 1.42× |
| 2012-03-31 | $14.97B | $13.63B | $1.06B | (m) | $6.06B | $5.33B | (m) | (m) | 1.10× |
| 2011-12-31 | $14.45B | $13.68B | $1.10B | (m) | $6.21B | $5.01B | (m) | $1.16B | 1.06× |
| 2011-09-30 | $13.02B | $11.48B | $1.08B | (m) | $5.61B | $4.67B | (m) | (m) | 1.13× |
| 2011-06-30 | $12.60B | $10.05B | $1.14B | (m) | $5.47B | $4.46B | (m) | (m) | 1.25× |
| 2011-03-31 | $12.05B | $8.88B | $721.00M | (m) | $5.58B | $4.22B | (m) | (m) | 1.36× |
| 2010-12-31 | $12.04B | $9.69B | $1.25B | (m) | $5.48B | $3.87B | (m) | $690.00M | 1.24× |
| 2010-09-30 | $11.86B | $9.32B | $935.00M | (m) | $5.23B | $3.86B | (m) | (m) | 1.27× |
| 2010-06-30 | $14.44B | $8.18B | $4.85B | (m) | $4.99B | $3.08B | (m) | (m) | 1.77× |
| 2010-03-31 | $12.61B | $8.34B | $2.36B | (m) | $5.14B | $3.24B | (m) | (m) | 1.51× |
| 2009-12-31 | $12.04B | $7.50B | $2.00B | (m) | $5.02B | $3.33B | (m) | $564.00M | 1.61× |
| 2009-09-30 | $11.46B | $7.23B | $1.60B | (m) | $4.69B | $3.45B | $2.19B | (m) | 1.58× |
| 2009-06-30 | $11.04B | $7.24B | $1.76B | (m) | $4.38B | $3.50B | (m) | (m) | 1.52× |
| 2009-03-31 | $11.14B | $8.57B | $2.35B | (m) | $4.13B | $3.21B | (m) | (m) | 1.30× |
| 2008-12-31 | $11.43B | $8.48B | $1.85B | (m) | $4.65B | $3.40B | (m) | (m) | 1.35× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.